RecruitingNot ApplicableNCT07737951

Tai Chi for Reducing Aromatase Inhibitor-Induced Arthralgia

Evaluating Tai Chi for Reducing Aromatase Inhibitor-Induced Arthralgia in Breast Cancer Survivors

Sponsor

Thomas Jefferson University

Enrollment

40 participants

Start Date

Jul 27, 2026

Study Type

INTERVENTIONAL

Conditions

Postmenopausal Breast Cancer Hormone Receptor-Positive Breast Carcinoma

Summary

The objective of the pilot RCT is to evaluate the feasibility and acceptability of a Tai Chi intervention "TaiChi4Joint" vs. an HE AC group for relieving AIIA in women with hormone receptor positive stage I-III BCa. The investigators will pilot test our data collection for mechanism measures via three innovatively integrated biobehavioral pathways.

Eligibility

Sex: FEMALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a behavioral approach called Health Education and a behavioral approach called Tai Chi for people with breast cancer, hormone receptor-positive breast carcinoma, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALTai Chi

Routine virtual Tai Chi group classes via Zoom for 1 hour, twice a week, for 12 weeks, three assessments: baseline, post-intervention follow-up and 2-month post-intervention follow-up.

BEHAVIORALHealth Education

Routine virtual AC classes delivered remotely, three assessments: baseline, post-intervention follow-up and 2-month post-intervention follow up.

Locations(1)

Sidney Kimmel Cancer Center at Thomas Jefferson University

Philadelphia, Pennsylvania, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07737951

Related Trials

Magseed Pro(R)/ Sentimag(R) Gen3

NCT051427876 locations

Combined Upper Extremity Resistance and Aerobic Exercise Training in Patients With Breast Cancer

NCT070707911 location

Collection of CSF Samples From Participants With Metastatic Triple Negative Breast Cancer (TNBC) and HER2+ Breast Cancer With no Prior History Nor Active Radiographically Detectable Brain Metastases

NCT07619534

A Study of Breast Cancer Risk Factors and Outcomes of People in Florida

NCT067801763 locations

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

NCT06058377545 locations